fbpx

PARP inhibitors

Jacinta’s Story of Ovarian Cancer – “emotional upheaval, despair, confusion, and now hope”

February is Ovarian Cancer Awareness Month. With ovarian cancer holding the lowest survival rate of any gynaecological cancer, awareness of symptoms and disease prevention are integral to women's health. Jacinta is a survivor of ovarian cancer, [...]

Jacinta’s Story of Ovarian Cancer – “emotional upheaval, despair, confusion, and now hope”2021-02-19T00:54:39+11:00

Could current trials hold promise for a major shift in the way we treat ovarian cancer?

Associate Professor Tarek Meniawy, Chair of the Ovarian Cancer Tumour Group, talks about recent advances in drug therapy, and why current trials underway hold promise for a major shift in standard practice and improved outcomes for [...]

Could current trials hold promise for a major shift in the way we treat ovarian cancer?2020-06-03T04:29:21+10:00
Go to Top